Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
The cryoablation devices market is experiencing rapid expansion, driven by advances in minimally invasive treatments and a growing need to address various medical conditions. With ongoing innovations and increasing adoption across multiple therapeutic areas, this market is set to continue its strong growth trajectory through 2030. Let’s explore the current market size, the key factors pushing growth, leading players, and emerging trends shaping the future of cryoablation technologies.
Cryoablation Devices Market Size and Growth Expectations
The market for cryoablation devices has seen swift growth recently, with revenues projected to rise from $0.61 billion in 2025 to $0.67 billion in 2026. This reflects a compound annual growth rate (CAGR) of 10.3%. The historical increase is largely driven by the rising prevalence of cancer and cardiac arrhythmias, widespread adoption of minimally invasive procedures, expansion of interventional oncology treatments, growth in cardiac electrophysiology services, and improved outcomes from cryoablation therapies. Moving forward, the market is anticipated to reach $0.96 billion by 2030, growing at a CAGR of 9.2%. This forecast growth is fueled by increased demand for organ-preserving cancer treatments, preference for minimally invasive surgery alternatives, greater use of ablation in early disease stages, expansion of specialized treatment centers, and continual technological improvements in ablation probes and systems. Key trends expected during this period include a surge in minimally invasive cryoablation procedures, more frequent applications in oncology and cardiology, wider adoption of image-guided ablation approaches, growth in outpatient and ambulatory treatments, and a rising need for precision-controlled tissue ablation.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17121&type=smp
Factors Driving Market Growth Related to Cardiovascular Disease
The rising incidence of cardiovascular diseases is a significant factor contributing to the growth of the cryoablation devices market. Cardiovascular diseases encompass a broad range of disorders affecting the heart and blood vessels, including coronary artery disease, hypertension, heart failure, arrhythmias, and stroke. This increase in prevalence is associated with aging populations, growing obesity rates, and heightened exposure to risk factors such as smoking and pollution. Cryoablation plays a critical role in cardiology by treating arrhythmias like atrial fibrillation through controlled lesion creation in heart tissue, which disrupts abnormal electrical signals and restores normal heart rhythms, thereby improving patient quality of life. For example, in 2023, Blackpool recorded 185 deaths due to cardiovascular disease, up from 178 in 2022, as reported by the UK’s Joint Strategic Needs Assessment in early 2025. Such data highlight how the growing burden of cardiovascular conditions is expected to drive demand for cryoablation devices.
The Impact of Increasing Healthcare Spending on Cryoablation Device Adoption
Another important factor encouraging market expansion is the rise in healthcare expenditure globally. Healthcare spending covers all medical services, public health initiatives, and health-related goods aimed at improving population health. This increase is largely attributed to the escalating prevalence of chronic diseases, which require continuous treatment, long-term medication, and ongoing medical care. Elevated healthcare budgets enable hospitals and clinics to invest in advanced minimally invasive technologies like cryoablation devices, increase procedural capacities, and broaden patient access to cutting-edge therapies. For instance, in 2023, healthcare spending in the United States rose by 7.5% to reach $4.9 trillion, averaging around $14,570 per person, according to the Centers for Medicare & Medicaid Services report from December 2024. This upward trend in healthcare investment is a key element driving the cryoablation devices market.
Access The Complete Cryoablation Devices Market Report:
https://www.thebusinessresearchcompany.com/report/cryoablation-devices-global-market-report
Detailed Segmentation of the Cryoablation Devices Market
This report breaks down the cryoablation devices market into several categories for a clearer understanding of revenue sources:
1) By Type: including Probe, Tissue Contact Probe Ablators, Epidermal and Subcutaneous Cryoablation Systems, Systems, Generators, Accessories and consumables
2) By Application: covering Cardiology, Oncology, and Other Applications
3) By End-Use: encompassing Hospitals, Ambulatory Surgical Centers, Specialty Centers, and Other End-Users
Further subcategories include:
– Probes such as Cryoprobes, Thermal Probes, and Radiofrequency Probes
– Tissue Contact Probe Ablators like Microwave Ablators, RF Ablators, Ultrasound Ablators
– Epidermal and Subcutaneous Cryoablation Systems classified as Spray-Based and Contact-Based Systems
– Systems divided into Standalone and Integrated Systems
– Generators categorized into High-Frequency and Low-Frequency Generators
– Accessories and Consumables including Needles, Catheters, Gas Cartridges, and Cooling Agents
Innovations Enhancing the Cryoablation Devices Market
Leading companies in the cryoablation sector are concentrating on developing innovative products to improve treatment precision and efficacy, such as advanced cryoprobes. These instruments are vital in cryotherapy, which involves freezing tissue to treat tumors, lesions, and other abnormal growths. For example, in May 2023, Varian—a Siemens Healthineers company—introduced the Isolis cryoprobe, a single-use disposable device designed to boost accuracy and efficiency in cryoablation procedures. It provides clinicians with enhanced control through its sharp tip and can integrate with Siemens Healthineers’ myNeedle Laser guidance system for precise probe placement, supporting better clinical outcomes.
Top Companies Leading the Cryoablation Devices Market
The cryoablation devices market features several prominent players, including Medtronic plc, Boston Scientific Corporation, CooperSurgical Inc., MicroPort Scientific Corporation, AtriCure Inc., Vimecon GmbH, Erbe Elektromedizin GmbH, MedGyn Products Inc., HealthTronics Inc., METRUM CRYOFLEX Sp. z o.o., Adagio Medical Inc., Channel Medsystems Inc., CPSI Biotech, CryoTherapeutics GmbH, Endocare Inc., Galil Medical Ltd., Sanarus Technologies Inc., IceCure Medical Ltd., AngioDynamics Inc., and CryoConcepts GmbH. These companies are actively shaping the market landscape through product development, strategic partnerships, and expanding distribution networks.
Regional Market Dynamics and Growth Potential
In 2025, North America held the largest share of the cryoablation devices market, reflecting strong adoption and developed healthcare infrastructure. Looking ahead, Asia-Pacific is expected to be the fastest-growing market region during the forecast period. The report also includes analysis of other key regions such as South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive view of global market trends and opportunities.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
